Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$276M |
| 2 |
IBM
IBM
|
+$272M |
| 3 |
Procter & Gamble
PG
|
+$161M |
| 4 |
Colgate-Palmolive
CL
|
+$151M |
| 5 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$405M |
| 2 |
CELG
Celgene Corp
CELG
|
+$207M |
| 3 |
Booking.com
BKNG
|
+$123M |
| 4 |
Eli Lilly
LLY
|
+$114M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 13.46% |
| 3 | Consumer Discretionary | 11.99% |
| 4 | Industrials | 10.52% |
| 5 | Consumer Staples | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Matsons
MATX
$6.11B
| $1.29M | ﹤0.01% |
48,100
-133,694
| -74% | -$3.26M |
|
1952
Compañía de Cervecerías Unidas
CCU
$2.14B
| $1.29M | ﹤0.01% |
55,100
-121,800
| -69% | -$2.81M |
|
|
RSE
1953
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $1.29M | ﹤0.01% |
+75,387
| New | +$1.26M |
|
1954
Comp X International
CIX
$352M
| $1.28M | ﹤0.01% |
122,900
+1,000
| +0.8% | +$10.3K |
|
1955
Korea Electric Power
KEP
$14.6B
| $1.28M | ﹤0.01% |
+69,700
| New | +$1.34M |
|
1956
EastGroup Properties
EGP
$11.2B
| $1.28M | ﹤0.01% |
19,900
-5,313
| -21% | -$337K |
|
1957
Agree Realty
ADC
$9.66B
| $1.28M | ﹤0.01% |
42,210
+910
| +2% | +$27.5K |
|
1958
MiMedx Group
MDXG
$630M
| $1.27M | ﹤0.01% |
+179,900
| New | +$1.05M |
|
1959
Novartis
NVS
$302B
| $1.27M | ﹤0.01% |
15,624
-91,512
| -85% | -$7.2M |
|
|
IMI
1960
DELISTED
Intermolecular, Inc.
IMI
| $1.27M | ﹤0.01% |
543,791
+185,166
| +52% | +$463K |
|
|
PNY
1961
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $1.26M | ﹤0.01% |
33,800
-102,500
| -75% | -$3.67M |
|
1962
Middlesex Water
MSEX
$1.07B
| $1.25M | ﹤0.01% |
59,178
+39,221
| +197% | +$809K |
|
1963
Entravision Communication
EVC
$1.02B
| $1.25M | ﹤0.01% |
200,839
-514,479
| -72% | -$2.86M |
|
|
ORM
1964
DELISTED
Owens Realty Mortgage, Inc.
ORM
| $1.25M | ﹤0.01% |
64,000
+32,400
| +103% | +$549K |
|
1965
York Water
YORW
$511M
| $1.24M | ﹤0.01% |
59,600
+8,646
| +17% | +$175K |
|
|
STBZ
1966
DELISTED
State Bank Financial Corporation. Common Stock
STBZ
| $1.24M | ﹤0.01% |
73,300
+33,500
| +84% | +$558K |
|
|
OIBR.C
1967
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $1.24M | ﹤0.01% |
2,559
+2,111
| +471% | +$1.13M |
|
1968
Cytokinetics
CYTK
$10.6B
| $1.23M | ﹤0.01% |
257,537
+69,470
| +37% | +$424K |
|
1969
Avista
AVA
$3.43B
| $1.23M | ﹤0.01% |
+36,700
| New | +$1.16M |
|
|
ONE
1970
DELISTED
HIGHER ONE HOLDINGS, INC COM STK
ONE
| $1.23M | ﹤0.01% |
322,484
+278,964
| +641% | +$1.36M |
|
|
SPRT
1971
DELISTED
support.com, Inc.
SPRT
| $1.23M | ﹤0.01% |
150,809
-16,483
| -10% | -$118K |
|
1972
State Street Utilities Select Sector SPDR ETF
XLU
$23.1B
| $1.22M | ﹤0.01% |
55,200
-40,000
| -42% | -$851K |
|
|
TAST
1973
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $1.22M | ﹤0.01% |
171,162
+98,258
| +135% | +$680K |
|
|
PVG
1974
DELISTED
PRETIUM RESOURCES INC.
PVG
| $1.22M | ﹤0.01% |
146,800
+135,500
| +1,199% | +$917K |
|
|
TAT
1975
DELISTED
TransAtlantic Petroleum LTD.
TAT
| $1.2M | ﹤0.01% |
+105,421
| New | +$959K |
|
Similar funds
Renaissance Technologies's Q2 2014 Portfolio in Review
As of Q2 2014, Renaissance Technologies held 3,246 positions worth $42.9B, up 2.9% from $41.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies's Q2 2014 filing shows 450 new, 1,273 increased, 1,008 reduced and 492 closed positions. Its largest new stake was Procter & Gamble: 2,001,729 shares worth $157M. The largest sale was Verizon, an estimated $405M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2014 buy was Procter & Gamble: 2,001,729 shares worth $157M.
- Renaissance Technologies added most to Pfizer in Q2 2014, an estimated $276M increase.
- Renaissance Technologies's biggest Q2 2014 reduction was Verizon, cutting an estimated $405M.
- Renaissance Technologies fully exited Booking.com in Q2 2014, selling an estimated $123M.
- Renaissance Technologies's ten largest holdings make up 14% of its $42.9B portfolio in Q2 2014.
- Renaissance Technologies opened 450 new positions and closed 492 in Q2 2014.
- Renaissance Technologies's portfolio value rose 2.9% quarter-over-quarter to $42.9B.
Based on Renaissance Technologies's 13F filing for Q2 2014, filed 13 Aug 2014.